Lombard Odier Asset Management (Europe)’s Maravai LifeSciences MRVI Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$434K	–	287
2024 Q1	$434K	Hold	50,000	–	–	0.03%	209
2023 Q4	$328K	Buy	50,000 +15,000	+43%	+$96.9K	0.02%	220
2023 Q3	$350K	Hold	35,000	–	–	0.02%	228
2023 Q2	$435K	Sell	35,000 -2,000	-5%	-$27K	0.02%	230
2023 Q1	$518K	Sell	37,000 -3,000	-8%	-$43.1K	0.03%	251
2022 Q4	$572K	Sell	40,000 -3,000	-7%	-$47.2K	0.02%	253
2022 Q3	$1.1M	Sell	43,000 -2,000	-4%	-$50.2K	0.06%	218
2022 Q2	$1.28M	Buy	+45,000	New	+$1.43M	0.06%	198

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s MRVI Position: Q2 2024 in Review

Lombard Odier Asset Management (Europe) sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 50,000 shares — an estimated $434K sold.

Lombard Odier Asset Management (Europe) first reported a position in MRVI in Q2 2022 and held it in 8 quarters. The position peaked at $1.28M in Q2 2022. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

Lombard Odier Asset Management (Europe) reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
Lombard Odier Asset Management (Europe) sold 50,000 Maravai LifeSciences shares in Q2 2024, an estimated $434K.
Lombard Odier Asset Management (Europe) first reported a position in Maravai LifeSciences in Q2 2022 and held it in 8 quarters.
Lombard Odier Asset Management (Europe)'s Maravai LifeSciences position peaked at $1.28M in Q2 2022.
206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2024, filed 14 Aug 2024.